Lucid Diagnostics Inc. (LUCD)
1.56
-0.03 (-1.89%)
At close: Mar 28, 2025, 3:04 PM
Lucid Diagnostics Ratios Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
PE Ratio | -0.91 | -1.12 | -0.88 | -6.53 | -52.54 | -98.41 | -386.38 |
PEG Ratio | 0.02 | 0.06 | -0.01 | -0.02 | -0.63 | -0.33 | n/a |
PS Ratio | 0.01 | 24.25 | 130.49 | 375.02 | n/a | n/a | n/a |
PB Ratio | 0.01 | -25.48 | 2.13 | 3.43 | -32.18 | -81.94 | -409.37 |
P/FCF Ratio | -0.00 | -1.78 | -1.61 | -10.12 | -77.29 | -184.22 | -3.83K |
P/OCF Ratio | -0.00 | -1.79 | -1.66 | -10.61 | -77.29 | -184.22 | -3.83K |
OCF/S Ratio | -10.16 | -13.52 | -78.74 | -35.34 | n/a | n/a | n/a |
Debt / Equity Ratio | 3.94 | -6.6 | 0.09 | n/a | n/a | n/a | n/a |
Quick Ratio | 1.07 | 0.74 | 2.88 | 13.34 | 0.04 | 0.06 | 0.02 |
Current Ratio | 1.07 | 0.75 | 2.89 | 13.45 | 0.09 | 0.06 | 0.02 |
Asset Turnover | 0.14 | 0.09 | 0.01 | 0.01 | n/a | n/a | n/a |
Interest Coverage | -1.77M | -116.54 | -7.02K | -41.61 | n/a | n/a | n/a |
Return on Equity (ROE) | -0.01 | 22.79 | -2.44 | -0.52 | 0.61 | 0.83 | 1.06 |
Return on Assets (ROA) | -0.00 | -1.93 | -1.73 | -0.49 | -3.77 | -4.28 | -63.25 |
Return on Capital (ROIC) | -6.4 | 22.96 | -2.33 | -0.5 | 0.61 | 0.83 | 1.06 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | -63.35% | -249.18% | -858.62% | -17% | n/a | n/a | n/a |
Net Profit Margin | -1.05% | -2.17K% | -14.9K% | -5.75K% | n/a | n/a | n/a |
Pretax Profit Margin | -1.05K% | -2.17K% | -14.9K% | -5.62K% | n/a | n/a | n/a |
Operating Profit Margin | -1.06K% | -2K% | -14.9K% | -5.48K% | n/a | n/a | n/a |
FCF Margin | -1.02K% | -1.36K% | -8.11K% | -3.71K% | n/a | n/a | n/a |
EBITDA Margin | -1.06K% | -2.05K% | -14.39K% | -5.48K% | n/a | n/a | n/a |